Risankizumab found to be noninferior, superior to ustekinumab for Crohn's disease
For patients with moderate-to-severe Crohn's disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the ...
Jul 18, 2024
0
2
What fat cats on a diet may tell us about obesity in humans
Pet cats may be excellent animal models for the study of obesity origins and treatment in humans, a new study of feline gut microbes suggests—and both species would likely get healthier in the research process, scientists ...
Jul 17, 2024
0
90
All FODMAPs aren't created equal: Working toward alternative diets to manage IBS
Two studies from Michigan Medicine may provide hope for patients with irritable bowel syndrome struggling to implement the traditional low-FODMAP diet.
Jul 17, 2024
0
0
Research reveals link between spinal muscular atrophy and liver damage
An international study has discovered that people living with the neurodegenerative condition spinal muscular atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA patients may face additional ...
Jul 17, 2024
0
0
Researchers show that age, sex and BMI are significantly associated with bowel movement frequency
Everybody poops, but not every day. New research by the Institute for Systems Biology (ISB) suggests bowel movement frequency is linked to long-term health.
Jul 16, 2024
0
80
Irritable bowel syndrome following gastroenteritis may last 4+ years in around half of those affected
Irritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a bout of gastroenteritis in around half of those affected, finds a pooled data analysis ...
Jul 16, 2024
0
23
Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds
Subcutaneous delivery of an anti-TNF inhibitor drug improved remission rates in patients with moderate-to-severe Crohn's disease and ulcerative colitis, according to recent phase 3 clinical trial results published in the ...
Jul 16, 2024
0
8
'We have treatments': Doctors urge patients with chronic vomiting to not suffer in silence
The American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize the signs and symptoms of cyclic vomiting syndrome (CVS). CVS is a common and disabling condition, ...
Jul 16, 2024
0
0
Research team explores etiologies of splenic venous hypertension
Splenic venous hypertension (SVH), also known as left-sided portal hypertension, is a rare condition characterized by upper gastrointestinal (GI) bleeding in the absence of liver disease. This condition arises due to increased ...
Jul 16, 2024
0
0
Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells
Autoimmune liver diseases (ALDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), are complex conditions involving the liver's immune-mediated damage. These ...
Jul 15, 2024
0
0
Belonging while battling bowel disease
Dealing with chronic conditions like Crohn's disease and ulcerative colitis can be challenging and sometimes embarrassing. Inflammatory bowel disease (IBD) can cause diarrhea, stomach pain, weight loss and other symptoms. ...
Jul 15, 2024
0
0
Cryptosporidiosis: What to know as gastro surges among Australian children
As a mother, I know the dread of hearing a gastro bug is going around the daycare, school or netball team. Diarrhea and vomiting can stun a healthy child for days and wreak havoc on a family for weeks.
Jul 12, 2024
0
0
Progress in the management of patients with cholestatic liver disease: Where are we and where are we going?
Cholestatic liver diseases (CLDs) are a group of disorders characterized by the impairment of bile formation, secretion, or excretion. This impairment leads to bile acid accumulation in the liver, causing liver biochemical ...
Jul 12, 2024
0
1
Research team develops new way for beneficial microbes to survive extreme conditions and space exploration
A team of researchers from Brigham and Women's Hospital have created formulations that allow microbial therapeutics, including those used to treat gastrointestinal diseases and improve crop production, to maintain their potency ...
Jul 11, 2024
0
0
Gut microbiota essential for PAHSAs' metabolic benefits in obese mice, study finds
Dietary lipids play an essential role in regulating the function of the gut microbiota and gastrointestinal tract, and these luminal interactions contribute to mediating host metabolism.
Jul 11, 2024
0
1
Study shows 13% of patients with dementia may instead have cognitive decline from cirrhosis
About 13% of individuals diagnosed with dementia may suffer instead from reversible cognitive decline caused by advanced liver disease, according to researchers from the Virginia Commonwealth University's School of Medicine ...
Jul 11, 2024
0
0
Study finds cirrhosis affects twice as many transgender adults as cisgender adults
Cirrhosis is chronic, progressive end-stage liver disease that occurs when scar tissue prevents the liver from functioning normally. Studies have shown that two of the leading causes of cirrhosis—alcohol use disorder and ...
Jul 10, 2024
0
8
The health benefits of going for a walk after a meal
Mairlyn Smith, a Canadian actress and cook, recently revealed on TikTok that she and her husband go for a walk after dinner to release their pent up gases. Smith calls these post-prandial strolls "fart walks." The hashtag ...
Jul 10, 2024
0
1
